BancorpSouth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
BancorpSouth's BIIB Position: Q3 2017 in Review
BancorpSouth reduced its Biogen (BIIB) stake by 6.5% in Q3 2017, selling an estimated $37.6K and leaving 1,823 shares worth $571K. The position accounts for 0.06% of the portfolio, ranked #124.
BancorpSouth first reported a position in BIIB in Q1 2016 and has held it in 7 quarters since. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.
- BancorpSouth held 1,823 shares of Biogen worth $571K as of Q3 2017.
- BancorpSouth sold 127 Biogen shares in Q3 2017, an estimated $37.6K.
- Biogen made up 0.06% of BancorpSouth's portfolio in Q3 2017, its #124 holding.
- BancorpSouth first reported a position in Biogen in Q1 2016 and has held it in 7 quarters since.
- 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.
Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.